Headband may ease withdrawal after cushing surgery
NCT ID NCT04543253
First seen Jun 24, 2026 · Last updated Sep 18, 2026 · Updated 2 times
Summary
This study looks at how people recover from Cushing syndrome after surgery. Researchers want to understand what affects recovery and whether using a MUSE biofeedback headband can help ease withdrawal symptoms. The study will include 700 adults who are planning to have curative surgery for Cushing syndrome.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- MUSE biofeedback headband
- What this could lead to
- If successful, this could point toward a way to reduce the severity of withdrawal symptoms after Cushing syndrome surgery.
- What could go wrong
- This is an early-stage study focused on symptom management, not a cure. The biofeedback device may not significantly improve recovery or quality of life.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 700 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jul 2019
- Expected to finish
-
Dec 2030
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Any male or female at least 18 years of age undergoing curative surgery for Cushing's Syndrome and MACS.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. age 18 and above, 2. new diagnosis of CS of any of the three subtypes (pituitary, adrenal or ectopic CS), and MACS, 3. planning for a curative surgery 4. ability to provide informed consent. Exclusion Criteria: 1. systemic supraphysiological GC for any reason within 1 month of enrollment, for more than 2 weeks, 2. inability to provide informed consent
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cushing syndrome are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Mayo Clinic
RECRUITINGRochester, Minnesota, 55905, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could muscle proteins reveal hidden muscle loss in diabetes and obesity?
- Hidden liver danger in Cushing's syndrome may reverse after cortisol cure
- New pill could tame hormone disorder Cushing's syndrome
- Scientists investigate adrenal tumors and seek better therapies
- New registry aims to unlock secrets of rare diseases
- New hope for Cushing's patients with high blood pressure